Evidence map›Paper›PMID 41901906›Full record

ArticlePolymers2026

Tracking Solar Optimization in Renewable Energy Systems by Using Multiplexed Holograms in Bayfol

Pedro Mas-Abellán, Pablo Beléndez, Jesús Gea-Caselles, José Carlos García-Vázquez, Belén Nieto-Rodríguez, Tomás Lloret, Inmaculada Pascual

Abstract read
In one paragraph

Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pedro Mas-AbellánThe Singular Theory (Singular Control Energy S.L.), Autovía de Alicante, km 52, 03400 Villena, Alicante, Spain.ORCID 0009-0006-6541-6463
Pablo BeléndezThe Singular Theory (Singular Control Energy S.L.), Autovía de Alicante, km 52, 03400 Villena, Alicante, Spain.ORCID 0009-0007-4930-766X
Jesús Gea-CasellesThe Singular Theory (Singular Control Energy S.L.), Autovía de Alicante, km 52, 03400 Villena, Alicante, Spain.ORCID 0009-0002-0984-0076
José Carlos García-VázquezI.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Carretera San Vicente del Raspeig s/n, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-9681-5217
Belén Nieto-RodríguezI.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Carretera San Vicente del Raspeig s/n, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-8675-2515
Tomás LloretI.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Carretera San Vicente del Raspeig s/n, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0002-1771-948X
Inmaculada PascualI.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Carretera San Vicente del Raspeig s/n, 03690 San Vicente del Raspeig, Alicante, Spain.ORCID 0000-0003-4602-6700

Funding

Generalitat Valenciana CIPROM/2024/90MCIN/AEI /10.13039/501100011033 PID2023-148881OB-I00
6 · The paper itself

Abstract

Multidisciplinary technologies are truly driving major transformations in industries, innovating to become more efficient. The need for more efficient renewable energy systems, such as solar energy, has recently been addressed with the innovation of using holographic photonic devices to avoid solar tracking devices as much as possible. In this work, a multiplexed holographic device is created and characterized for use in front of a photocell, thereby eliminating the need for tracking systems due to its wide acceptance angle and high diffraction efficiency. Commercial Bayfol

Indexed as

commercial photopolymerholographymultiplexed hologramsphotopolymersrenewal energy

Identifiers

PMID41901906
PMCPMC13030547

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.